How Much Does It Cost to Make Mounjaro — and Why Does That Matter for What You Pay?

What does it actually cost to make a weight-loss medicine like Mounjaro?

Eli Lilly has never published a manufacturing cost figure for tirzepatide, and the research, development and regulatory pathway that brought it to market represents billions in investment spread across the SURMOUNT clinical programme and the trials preceding it. What independent health economists can say is that the list price of any brand medicine reflects far more than factory overhead: patent protection, regulatory compliance, pharmacovigilance, and ongoing safety monitoring all contribute. That context matters when you see private prices and wonder whether they are inflated.

In practical terms, the figure that shapes what UK patients pay is Eli Lilly's UK list price, not a manufacturing cost. Eli Lilly raised its UK list price from 1 September 2025; at the highest dose, the list price moved from around £122 to around £330 per four-week pen, as widely reported in August 2025. Private clinics and pharmacies price from there, adding their own clinical, operational and regulatory costs. Typical private prices since that change have ranged roughly £149–£375 per month depending on dose and provider. Those are the numbers worth understanding when you are comparing what different services charge. If you want to understand how much Mounjaro goes up to across the full dose range, our pricing page breaks it down clearly. You can explore how much the 5mg Mounjaro pen costs, which is the starting dose most patients begin on, on our dedicated pricing page. You can explore how current pricing breaks down across the dose range on our Mounjaro pricing page.

Mounjaro's trial evidence is strong. SURMOUNT-1 reported an average body-weight reduction of around 20–21% at 15mg over 72 weeks, as published in the New England Journal of Medicine, results achieved in trials conducted under supervised clinical conditions alongside lifestyle support, not in isolation.

Why do headline prices between providers vary so much?

The short answer is that headline prices are not always describing the same thing. Some services quote the pen price alone. Others fold in a consultation fee separately. Delivery may be charged on top, and aftercare (the clinical support between pens) is sometimes absent entirely or available only at an extra cost. If you are comparing providers on price alone, you are often comparing different bundles.

The things most likely to be missing from a lower headline number include a genuine clinical assessment before treatment starts, a prescriber review before dose increases, any form of ongoing contact if side effects emerge, and delivery. For a prescription-only medicine, those are not optional extras. NICE's appraisal of tirzepatide (TA1026) was developed in the context of supervised, supported use, that framing is relevant when you consider what responsible private prescribing should include.

It is also worth knowing how to verify any pharmacy you are considering. The GPhC maintains a live register of all legally operating UK pharmacies at pharmacyregulation.org/registers, worth a quick check before you hand over payment details anywhere.

Where does nume sit on price, and what is included?

We are not the cheapest provider, and that is a deliberate choice. A single transparent price at nume covers your consultation, the prescription, the medicine, and free next-working-day delivery, your pen arrives via DPD in plain, unbranded packaging, trackable on your phone. There are no hidden prescription charges, no delivery fees added at checkout, and no subscription locking you into future orders. Every repeat is independently re-reviewed by a prescriber before it is approved. That clinical review is built into what you pay, not invoiced separately.

Our prescribers are GPhC-registered Independent Prescribers. A real clinician reads your consultation answers the same day, not a triage algorithm. If you want to understand the full Mounjaro treatment journey before deciding, our Mounjaro overview covers what to expect from start to finish. For a breakdown of what each dose costs with us, see the full guide to what the Mounjaro jab costs.

Why is asking 'how much does it cost to make' ultimately the wrong question?

Manufacturing cost is not the measure that protects you. A pen produced cheaply and sold without proper clinical assessment carries risks that a well-priced legitimate supply does not. The MHRA has warned repeatedly about counterfeit weight-loss pens sold online, fake pens have reached UK buyers containing substances other than tirzepatide, including insulin. In October 2025, the first UK site producing counterfeit tirzepatide pens was raided. The MHRA's advice is unambiguous: only obtain these medicines through a pharmacy you can verify on the GPhC register, following a genuine prescriber assessment.

Price tells you what you are spending. It does not tell you what is inside the pen, who reviewed whether it is right for you, or who you can call if something goes wrong. For a prescription medicine, those are the questions worth asking. Many patients also ask how much Mounjaro costs on the NHS and whether that route might be available to them. Our clinical team and our GPhC-registered pharmacy (registration number 9012878, verifiable at the GPhC register) exist precisely because they are. If you are ready to take the next step, speak to our prescribers, the consultation is free.